Stada’s €5bn LBO to heat up post-summer pipeline

The European leveraged finance markets are licking their lips in anticipation of a new €2.5bn deal backing Bain and Cinven’s takeover of Stada Arzneimittel, the German generic drug manufacturer.

  • By Victor Jimenez
  • 12 Jul 2017

The two private equity firms increased Stada’s takeover valuation by €16m on Monday, raising their new bid from €66 a share to €66.25. Stada’s board backed the raised offer. 

However, the increased offer represents a second bid in just two weeks and will need Germany’s federal financial supervisory authority ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 15,608.24 61 6.88%
2 BNP Paribas 14,498.69 78 6.39%
3 Goldman Sachs 13,002.56 50 5.73%
4 HSBC 12,340.95 74 5.44%
5 Deutsche Bank 11,531.87 64 5.08%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 5,335.13 43 7.86%
2 Goldman Sachs 4,801.82 38 7.07%
3 Deutsche Bank 4,643.96 44 6.84%
4 Credit Suisse 4,353.57 48 6.41%
5 Barclays 4,156.24 35 6.12%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 27,143.08 213 10.83%
2 Citi 21,041.57 167 8.39%
3 Bank of America Merrill Lynch 20,960.58 186 8.36%
4 Goldman Sachs 18,419.20 133 7.35%
5 Morgan Stanley 17,410.41 103 6.94%